Cargando…
Personalized medicine: Vinpocetine to reverse effects of GABRB3 mutation
OBJECTIVE: To screen a library of potential therapeutic compounds for a woman with Lennox‐Gastaut syndrome due to a Y302C GABRB3 (c.905A>G) mutation. METHODS: We compared the electrophysiological properties of cells with wild‐type or the pathogenic GABRB3 mutation. RESULTS: Among 1320 compounds,...
Autores principales: | Billakota, Santoshi, Andresen, J. Michael, Gay, Bryant C., Stewart, Gregory R., Fedorov, Nikolai B., Gerlach, Aaron C., Devinsky, Orrin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004153/ https://www.ncbi.nlm.nih.gov/pubmed/31755996 http://dx.doi.org/10.1111/epi.16394 |
Ejemplares similares
-
Long‐term cannabidiol treatment in patients with Dravet syndrome: An open‐label extension trial
por: Devinsky, Orrin, et al.
Publicado: (2018) -
Cannabidiol in patients with Lennox‐Gastaut syndrome: Interim analysis of an open‐label extension study
por: Thiele, Elizabeth, et al.
Publicado: (2019) -
EGFR Blockade Reverses Cisplatin Resistance in Human Epithelial Ovarian Cancer Cells
por: Poursheikhani, Arash, et al.
Publicado: (2020) -
Standard median nerve ultrasound in carpal tunnel syndrome: A retrospective review of 1,021 cases()
por: Billakota, Santoshi, et al.
Publicado: (2017) -
In silico Identification of Hypoxic Signature followed by reverse transcription-quantitative PCR Validation in Cancer Cell Lines
por: Shayan, Sara, et al.
Publicado: (2023)